NGFR P210 | Addgene 27486 product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

Addgene

product type :

cDNA

product name :

NGFR P210

catalog :

27486

citations: 3

Reference
Wahiduzzaman M, Ota A, Karnan S, Hanamura I, Mizuno S, Kanasugi J, et al. Novel combined Ato-C treatment synergistically suppresses proliferation of Bcr-Abl-positive leukemic cells in vitro and in vivo. Cancer Lett. 2018;433:117-130 pubmed publisher
Shin J, Mooney D. Extracellular matrix stiffness causes systematic variations in proliferation and chemosensitivity in myeloid leukemias. Proc Natl Acad Sci U S A. 2016;113:12126-12131 pubmed
He Y, Wertheim J, Xu L, Miller J, Karnell F, Choi J, et al. The coiled-coil domain and Tyr177 of bcr are required to induce a murine chronic myelogenous leukemia-like disease by bcr/abl. Blood. 2002;99:2957-68 pubmed

product information

Catalog Number :

27486

Product Name :

NGFR P210

article :

doi	10.1182/blood.V99.8.2957
id	3962
pubmed_id	11929787

bacterial resistance :

Ampicillin

cloning :

backbone

NGFR

backbone_mutation

backbone_origin

Warren Pear Lab

backbone_size

promoter

sequencing_primer_3

sequencing_primer_5

vector_types

Mammalian Expression

Retroviral

origin :

pi :

alt_names

bcr/abl

cloning

clone_method	Restriction Enzyme
cloning_site_3
cloning_site_5
promoter
sequencing_primer_3
sequencing_primer_5	pLXSN 5'
site_3_destroyed
site_5_destroyed

entrez_gene

aliases	ABL, BCR-ABL, CHDSKM, JTK7, bcr/abl, c-ABL, c-ABL1, p150, v-abl
gene	ABL1
id	25

aliases	ALL, BCR1, CML, D22S11, D22S662, PHL
gene	BCR
id	613

genbank_ids

mutation

Contains the complete bcr/abl fusion

name

bcr/abl (P210)

shRNA_sequence

size

7200

species

9606

Homo sapiens